mouse anti β3 tubulin (Cell Signaling Technology Inc)
Cell Signaling Technology Inc is a verified supplier 
Cell Signaling Technology Inc manufactures this product 
95
Structured Review
Cell Signaling Technology Inc
mouse anti β3 tubulin
Mouse Anti β3 Tubulin, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 187 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti+%CE%B23+tubulin/beta3-Tubulin+(TU-20)+Mouse+mAb/pm41643835-79-27-31
Average 95 stars, based on 187 article reviews
Mouse Anti β3 Tubulin, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 187 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti+%CE%B23+tubulin/beta3-Tubulin+(TU-20)+Mouse+mAb/pm41643835-79-27-31
Average 95 stars, based on 187 article reviews
mouse anti β3 tubulin - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
Staining:Article Title: An adhesion signaling axis involving Dystroglycan, β1-Integrin, and Cas adaptor proteins regulates the establishment of the cortical glial scaffold Article Snippet: .. Untransfected cells were stained with the following primary antibodies: rabbit anti-Blbp (1:500, Abcam# ab32423), Article Title: An adhesion signaling axis involving Dystroglycan, β1-Integrin, and Cas adaptor proteins regulates the establishment of the cortical glial scaffold. Article Snippet: .. Untransfected cells were stained with the following primary antibodies: rabbit anti-Blbp (1:500, Abcam# ab32423), Immunofluorescence:Article Title: Olfactory Neuron Prokineticin-2 as a Potential Target in Parkinson's Disease. Article Snippet: Objective: The objective of this study was to outline the dynamics of prokineticin-2 pathway in relation to clinicalpathological features of Parkinson’s disease by examining olfactory neurons of patients.. Methods: Thirty-eight patients (26 de novo, newly diagnosed) and 31 sex/age-matched healthy controls underwent noninvasive mucosa brushing for olfactory neurons collection, and standard clinical assessment.. Gene expression levels of prokineticin-2, prokineticin-2 receptors type 1 and 2, and prokineticin-2-long peptide were measured in olfactory neurons by real-time polymerase chain reaction (PCR); moreover, the prokineticin-2 protein and α-synuclein species (total and oligomeric) were quantified by immunofluorescence staining. Blocking Assay:Article Title: Olfactory Neuron Prokineticin-2 as a Potential Target in Parkinson's Disease. Article Snippet: Objective: The objective of this study was to outline the dynamics of prokineticin-2 pathway in relation to clinicalpathological features of Parkinson’s disease by examining olfactory neurons of patients.. Methods: Thirty-eight patients (26 de novo, newly diagnosed) and 31 sex/age-matched healthy controls underwent noninvasive mucosa brushing for olfactory neurons collection, and standard clinical assessment.. Gene expression levels of prokineticin-2, prokineticin-2 receptors type 1 and 2, and prokineticin-2-long peptide were measured in olfactory neurons by real-time polymerase chain reaction (PCR); moreover, the prokineticin-2 protein and α-synuclein species (total and oligomeric) were quantified by immunofluorescence staining. Article Title: Gut-first Parkinson’s disease is encoded by gut dysbiome Article Snippet: .. Briefly, samples were incubated with rabbit anti-ZO-1 (Abcam, 1:300), mouse anti-CD11b (BioRad, 1:200), rabbit anti-CD4 (Cell Signaling, 1:200), rabbit anti-TOM20 (Santa Cruz, 1:400), Incubation:Article Title: Olfactory Neuron Prokineticin-2 as a Potential Target in Parkinson's Disease. Article Snippet: Objective: The objective of this study was to outline the dynamics of prokineticin-2 pathway in relation to clinicalpathological features of Parkinson’s disease by examining olfactory neurons of patients.. Methods: Thirty-eight patients (26 de novo, newly diagnosed) and 31 sex/age-matched healthy controls underwent noninvasive mucosa brushing for olfactory neurons collection, and standard clinical assessment.. Gene expression levels of prokineticin-2, prokineticin-2 receptors type 1 and 2, and prokineticin-2-long peptide were measured in olfactory neurons by real-time polymerase chain reaction (PCR); moreover, the prokineticin-2 protein and α-synuclein species (total and oligomeric) were quantified by immunofluorescence staining. Article Title: Gut-first Parkinson’s disease is encoded by gut dysbiome Article Snippet: .. Briefly, samples were incubated with rabbit anti-ZO-1 (Abcam, 1:300), mouse anti-CD11b (BioRad, 1:200), rabbit anti-CD4 (Cell Signaling, 1:200), rabbit anti-TOM20 (Santa Cruz, 1:400), Binding Assay:Article Title: Olfactory Neuron Prokineticin-2 as a Potential Target in Parkinson's Disease. Article Snippet: Objective: The objective of this study was to outline the dynamics of prokineticin-2 pathway in relation to clinicalpathological features of Parkinson’s disease by examining olfactory neurons of patients.. Methods: Thirty-eight patients (26 de novo, newly diagnosed) and 31 sex/age-matched healthy controls underwent noninvasive mucosa brushing for olfactory neurons collection, and standard clinical assessment.. Gene expression levels of prokineticin-2, prokineticin-2 receptors type 1 and 2, and prokineticin-2-long peptide were measured in olfactory neurons by real-time polymerase chain reaction (PCR); moreover, the prokineticin-2 protein and α-synuclein species (total and oligomeric) were quantified by immunofluorescence staining. Olfactory:Article Title: Olfactory Neuron Prokineticin-2 as a Potential Target in Parkinson's Disease. Article Snippet: Objective: The objective of this study was to outline the dynamics of prokineticin-2 pathway in relation to clinicalpathological features of Parkinson’s disease by examining olfactory neurons of patients.. Methods: Thirty-eight patients (26 de novo, newly diagnosed) and 31 sex/age-matched healthy controls underwent noninvasive mucosa brushing for olfactory neurons collection, and standard clinical assessment.. Gene expression levels of prokineticin-2, prokineticin-2 receptors type 1 and 2, and prokineticin-2-long peptide were measured in olfactory neurons by real-time polymerase chain reaction (PCR); moreover, the prokineticin-2 protein and α-synuclein species (total and oligomeric) were quantified by immunofluorescence staining. Marker:Article Title: Olfactory Neuron Prokineticin-2 as a Potential Target in Parkinson's Disease. Article Snippet: Objective: The objective of this study was to outline the dynamics of prokineticin-2 pathway in relation to clinicalpathological features of Parkinson’s disease by examining olfactory neurons of patients.. Methods: Thirty-eight patients (26 de novo, newly diagnosed) and 31 sex/age-matched healthy controls underwent noninvasive mucosa brushing for olfactory neurons collection, and standard clinical assessment.. Gene expression levels of prokineticin-2, prokineticin-2 receptors type 1 and 2, and prokineticin-2-long peptide were measured in olfactory neurons by real-time polymerase chain reaction (PCR); moreover, the prokineticin-2 protein and α-synuclein species (total and oligomeric) were quantified by immunofluorescence staining. Expressing:Article Title: Devices and methods for isolating a migratory cell population Article Snippet: The chemiluminescent substrate (Santa Cruz Biotechnology) was introduced to the membrane and signals of the target protein on X-ray Film (Lightlabs) were developed using a film processor (Mini-Med, AFP Imaging). .. Mouse anti-Vimentin (1:1000, Invitrogen), mouse anti-Met (1:1000, Cell Signaling Technology) and other:Article Title: LPS-induced mitochondrial dysfunction regulates innate immunity activation and α-synuclein oligomerization in Parkinson's disease Article Snippet: |